• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[动脉高血压及与糖尿病相关的心血管危险因素。初级医疗中PHARE调查的报告]

[Aterial hypertension and cardiovascular risk factors associated with diabetes. Report of the PHARE survey in general practice].

作者信息

Chamontin B, Lang T, Vaisse B, Nicodeme R, Antoine M P, Lazorthes M L, Gallois H, Poggi L

机构信息

Service de médecine interne et HTA, CHU Purpan, Toulouse.

出版信息

Arch Mal Coeur Vaiss. 2001 Aug;94(8):869-73.

PMID:11575221
Abstract

OBJECTIVE

To evaluate the characteristics of diabetic hypertensive patients (Pts), in term of associated cardiovascular risk factors and blood pressure control in a representative population issued from a survey "PHARE" conducted in general practice in France in 1999.

DESIGN AND METHODS

PHARE survey was conducted in a sample of 225 GPs representative of the French medical population included in a gallup poll. GPs had to include all patients > 18 years old over a period of one week. Pts were considered as hypertensives (HP) if the mean of two recorded BP measurements was = 140/90 mmHg and/or < 140/90 mmHg if they were under antihypertensive treatment. Patients were considered as diabetics if they were previously known and/or if they received a medication for diabetes. Hypertensives were considered as controlled if their BP levels were overall < 140/90 mmHg or at the recommended threshold < 130/85 mmHg under treatment.

RESULTS

877 diabetic Pts (7%) among 12.342 Pts and 5.190 HP were included in the study. When compared to normotensives, diabetic HP had more frequently associated risk factors with hypertension and diabetes: overweight 71% vs 45%, dyslipidemia 61% vs 34%, sendentarily 73% vs 63%, tobacco consumption 27% vs 20%. The BP control at 140/90 mmHg threshold among treated diabetic HP was 21%, and only 8% at 130/85 mmHg. Regarding WHO classification, 79% of these diabetics had a high or very high cardiovascular risk. The were no difference in antihypertensive drugs used in HP diabetics and non diabetics and 50% of them received ACEI.

CONCLUSIONS

8 from 10 diabetics taken in charge in general practice are hypertensives and 8 from 10 have a very high cardiovascular risk due to a poor BP control and associated cardiovascular risk factors.

摘要

目的

在1999年法国普通科开展的一项“灯塔”(PHARE)调查所涵盖的具有代表性人群中,从相关心血管危险因素和血压控制方面评估糖尿病高血压患者的特征。

设计与方法

“灯塔”调查在225名代表法国医学人群的全科医生样本中进行,这些医生参与了一项盖洛普民意调查。全科医生必须纳入在一周时间内所有年龄大于18岁的患者。如果两次记录的血压测量平均值 = 140/90 mmHg,则患者被视为高血压患者(HP);如果他们正在接受抗高血压治疗且血压 < 140/90 mmHg,也被视为高血压患者。如果患者既往已知患有糖尿病和/或正在接受糖尿病药物治疗,则被视为糖尿病患者。如果高血压患者的血压水平总体 < 140/90 mmHg 或在治疗时处于推荐阈值 < 130/85 mmHg,则被视为血压得到控制。

结果

12342名患者中有877名糖尿病患者(7%)和5190名高血压患者被纳入研究。与血压正常者相比,糖尿病高血压患者更常伴有高血压和糖尿病相关的危险因素:超重分别为71% 对 45%,血脂异常分别为61% 对 34%,久坐分别为73% 对 63%,吸烟分别为27% 对 20%。在接受治疗的糖尿病高血压患者中,血压控制在140/90 mmHg阈值的比例为21%,在130/85 mmHg时仅为8%。根据世界卫生组织分类,这些糖尿病患者中有79%具有高或非常高的心血管风险。糖尿病高血压患者和非糖尿病高血压患者使用的抗高血压药物没有差异,其中50%接受了血管紧张素转换酶抑制剂(ACEI)。

结论

在普通科诊治的糖尿病患者中,十分之八为高血压患者,并且由于血压控制不佳和相关心血管危险因素,十分之八具有非常高的心血管风险。

相似文献

1
[Aterial hypertension and cardiovascular risk factors associated with diabetes. Report of the PHARE survey in general practice].[动脉高血压及与糖尿病相关的心血管危险因素。初级医疗中PHARE调查的报告]
Arch Mal Coeur Vaiss. 2001 Aug;94(8):869-73.
2
[Regional management of arterial hypertension in France. Report of a survey of general practitioners].
Arch Mal Coeur Vaiss. 2001 Aug;94(8):823-7.
3
[Management of severe hypertension in France in 1999 and 2000: intermediate results of a health insurance intervention program].[1999年和2000年法国重度高血压的管理:一项医疗保险干预计划的中期结果]
Arch Mal Coeur Vaiss. 2002 Jul-Aug;95(7-8):687-94.
4
[Influence of cardiovascular risk factors on prescribing of antihypertensives].[心血管危险因素对降压药处方的影响]
Arch Mal Coeur Vaiss. 2001 Aug;94(8):846-50.
5
[Arterial hypertension management in general practice in France according to global risk factors].[根据全球风险因素对法国全科医疗中动脉高血压的管理]
Arch Mal Coeur Vaiss. 2001 Aug;94(8):843-5.
6
[Management of essential arterial hypertension and cardiovascular risk levels. Observation in general medicine: national PHENOMEN study. Evaluation and stratification of cardiovascular risk based on the 2000 ANAES recommendations in a population of hypertensive patients].[原发性动脉高血压与心血管风险水平的管理。全科医学观察:全国PHENOMEN研究。基于2000年ANAES建议对高血压患者群体进行心血管风险评估与分层]
Arch Mal Coeur Vaiss. 2002 Jul-Aug;95(7-8):667-72.
7
[Prevalence, treatment and control of hypertension in family practice patients in France during 1994].[1994年法国家庭医疗患者中高血压的患病率、治疗与控制情况]
Arch Mal Coeur Vaiss. 1996 Aug;89(8):1075-80.
8
[Blood pressure control in hypertensive patients with stable coronary heart disease].[稳定型冠心病高血压患者的血压控制]
Arch Mal Coeur Vaiss. 2005 Jul-Aug;98(7-8):795-9.
9
[Estimation of the number of patients treated for hypertension, diabetes or hyperlipidemia in France: FLAHS study 2002].[法国高血压、糖尿病或高脂血症治疗患者数量的估计:2002年法国全国健康与营养调查(FLAHS)研究]
Arch Mal Coeur Vaiss. 2003 Jul-Aug;96(7-8):750-3.
10
[Arterial hypertension of the aged patient in general medicine. French national survey].[老年患者的动脉高血压在普通医学中的情况。法国全国性调查]
Arch Mal Coeur Vaiss. 1999 Aug;92(8):1089-94.

引用本文的文献

1
[Blood count results from hypertensive patients seen in laboratory of CHU-HJRB Antananarivo in 2013].[2013年在塔那那利佛CHU-HJRB实验室就诊的高血压患者的血细胞计数结果]
Pan Afr Med J. 2016 Feb 19;23:49. doi: 10.11604/pamj.2016.23.49.8900. eCollection 2016.
2
Performance scores in general practice: a comparison between the clinical versus medication-based approach to identify target populations.一般实践中的绩效评分:基于临床与药物的方法识别目标人群的比较。
PLoS One. 2012;7(4):e35721. doi: 10.1371/journal.pone.0035721. Epub 2012 Apr 20.
3
Treatment and blood pressure control in 47,964 people with diabetes and hypertension: a systematic review of observational studies.
47964例糖尿病合并高血压患者的治疗与血压控制:观察性研究的系统评价
Can J Cardiol. 2006 Aug;22(10):855-60. doi: 10.1016/s0828-282x(06)70304-x.